semaglutide vs tirzepatide which is better Not all GLP-1s are the
Description
Wegovy (semaglutide): a new weight loss drug for chronic weight management
As of now No hearings scheduled There is no publicly scheduled committee hearing yet
GLP-1 medications can interact with diabetes medications and other prescriptions
In contrast, the placebo (inactive treatment) group lost about 6 pounds on average, or about 2% of their body weight
